- 大部份公司都有淡旺季, 所以通常是看年增率
- 如果是成長期(在炒新的成長動能)的公司或景氣從谷底翻揚, 就可以觀察月增率
- 漲很多的股票要留意營收年增率或月增率大幅減少, 又或者是合約負債已經開始減少
- 留意短期平均營收向上或向下穿越長期平均營收
- 觀察累計營收年增率的累計增加或虧損收斂
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/11 | 1.52 | -1.79 | 1.07 | 17.5 | 24.19 | 4.7 | N/A | - | ||
| 2024/10 | 1.54 | -5.91 | -2.04 | 15.99 | 26.94 | 4.89 | N/A | - | ||
| 2024/9 | 1.64 | -3.61 | 7.35 | 14.45 | 31.15 | 5.06 | 0.68 | - | ||
| 2024/8 | 1.7 | -0.88 | 12.66 | 12.81 | 34.97 | 4.99 | 0.69 | - | ||
| 2024/7 | 1.72 | 9.59 | 36.62 | 11.11 | 39.2 | 4.91 | 0.7 | - | ||
| 2024/6 | 1.57 | -3.19 | 42.86 | 9.38 | 39.56 | 4.73 | 0.74 | - | ||
| 2024/5 | 1.62 | 4.94 | 23.07 | 7.81 | 39.02 | 4.58 | 0.76 | - | ||
| 2024/4 | 1.54 | 8.9 | 36.13 | 6.19 | 43.89 | 4.34 | 0.8 | - | ||
| 2024/3 | 1.42 | 2.85 | 18.81 | 4.62 | 45.87 | 4.62 | 0.66 | - | ||
| 2024/2 | 1.38 | -24.63 | 25.93 | 3.21 | 61.69 | 4.57 | 0.66 | 因去年基期較低，致本期增加百分比遞增。 | ||
| 2024/1 | 1.83 | 33.57 | 105.73 | 1.83 | 105.73 | 4.7 | 0.65 | 因去年基期較低，致本期增加百分比遞增。 | ||
| 2023/12 | 1.37 | -8.79 | 29.51 | 15.46 | -3.27 | 4.45 | 0.75 | - | ||
| 2023/11 | 1.5 | -4.82 | 25.18 | 14.09 | -5.3 | 4.61 | 0.73 | - | ||
| 2023/10 | 1.58 | 3.11 | 69.64 | 12.59 | -7.97 | 4.62 | 0.73 | 本期營收增加金額達50%以上，係因去年同期基期較低造成。 | ||
| 2023/9 | 1.53 | 1.14 | 33.29 | 11.02 | -13.62 | 4.3 | 0.58 | - | ||
| 2023/8 | 1.51 | 20.19 | 63.67 | 9.49 | -17.86 | 3.87 | 0.64 | 本期營收增加金額達50%以上，係因去年同期基期較低造成。 | ||
| 2023/7 | 1.26 | 14.6 | 47.79 | 7.98 | -24.94 | 3.67 | 0.68 | - | ||
| 2023/6 | 1.1 | -16.6 | 32.49 | 6.72 | -31.32 | 3.55 | 0.69 | - | ||
| 2023/5 | 1.32 | 16.07 | -5.18 | 5.62 | -36.97 | 3.64 | 0.67 | - | ||
| 2023/4 | 1.13 | -4.94 | -42.43 | 4.3 | -42.83 | 3.42 | 0.71 | - | ||
| 2023/3 | 1.19 | 9.01 | -46.13 | 3.18 | -42.86 | 3.18 | 0.78 | - | ||
| 2023/2 | 1.09 | 23.12 | -18.14 | 1.98 | -40.5 | 3.04 | 0.82 | - | ||
| 2023/1 | 0.89 | -15.91 | -55.47 | 0.89 | -55.47 | 3.14 | 0.79 | 本月因農曆春節連假影響出貨,致營收額相對去年減少. | ||
| 2022/12 | 1.06 | -11.83 | -43.28 | 15.94 | -34.1 | 3.18 | 0.84 | - | ||
| 2022/11 | 1.2 | 28.98 | -33.61 | 14.88 | -33.32 | 3.27 | 0.81 | - | ||
| 2022/10 | 0.93 | -18.97 | -46.0 | 13.68 | -33.29 | 3.0 | 0.89 | - | ||
| 2022/9 | 1.15 | 24.19 | -39.06 | 12.7 | -32.42 | 2.92 | 1.01 | - | ||
| 2022/8 | 0.92 | 8.53 | -40.77 | 11.55 | -31.74 | 2.6 | 1.13 | - | ||
| 2022/7 | 0.85 | 2.73 | -41.55 | 10.63 | -30.82 | 3.07 | 0.96 | - | ||
| 2022/6 | 0.83 | -40.32 | -48.68 | 9.74 | -29.96 | 4.19 | 0.89 | - | ||
| 2022/5 | 1.39 | -29.53 | -33.1 | 8.91 | -27.6 | 5.57 | 0.67 | - | ||
| 2022/4 | 1.97 | -11.05 | -23.45 | 7.53 | -26.48 | 5.52 | 0.68 | - | ||
| 2022/3 | 2.21 | 65.65 | -18.74 | 5.55 | -27.65 | 5.55 | 0.51 | - | ||
| 2022/2 | 1.34 | -33.02 | -39.77 | 3.33 | -32.51 | 5.2 | 0.54 | - | ||
| 2022/1 | 2.0 | 7.09 | -26.58 | 2.0 | -26.58 | 5.66 | 0.5 | - | ||
| 2021/12 | 1.86 | 3.19 | -20.54 | 24.18 | -10.18 | 5.39 | 0.61 | - | ||
| 2021/11 | 1.81 | 4.9 | -32.96 | 22.32 | -9.2 | 5.41 | 0.6 | - | ||
| 2021/10 | 1.72 | -8.56 | -42.5 | 20.52 | -6.28 | 5.16 | 0.63 | - | ||
| 2021/9 | 1.88 | 20.7 | -32.64 | 18.81 | -0.47 | 4.9 | 0.56 | - | ||
| 2021/8 | 1.56 | 7.1 | -40.9 | 16.93 | 5.01 | 4.63 | 0.59 | - | ||
| 2021/7 | 1.46 | -9.79 | -35.73 | 15.37 | 13.99 | 5.14 | 0.53 | - | ||
| 2021/6 | 1.61 | -22.2 | -31.89 | 13.93 | 24.19 | 6.26 | 0.5 | - | ||
| 2021/5 | 2.07 | -19.36 | -14.6 | 12.31 | 39.35 | 7.37 | 0.43 | - | ||
| 2021/4 | 2.57 | -5.57 | 13.95 | 10.24 | 59.81 | 7.52 | 0.42 | 營收相較去年增加原因為去年同期受新冠肺炎疫情影響及本年度新產品出貨數量增加所致。 | ||
| 2021/3 | 2.72 | 22.78 | 37.62 | 7.66 | 84.68 | 7.66 | 0.32 | 營收相較去年增加原因為去年同期受新冠肺炎疫情影響及本年度新產品出貨數量增加所致。 | ||
| 2021/2 | 2.22 | -18.36 | 181.64 | 4.94 | 127.62 | 7.28 | 0.34 | 去年新冠肺炎疫情影響復工，造成同期基期較低。 | ||
| 2021/1 | 2.72 | 15.91 | 96.8 | 2.72 | 96.8 | 7.76 | 0.31 | 去年同期因農曆年假影響，相對基期較低。 | ||
| 2020/12 | 2.35 | -12.93 | 4.71 | 26.93 | -22.44 | 8.03 | 0.41 | - | ||
| 2020/11 | 2.69 | -10.01 | -6.6 | 24.59 | -24.29 | 8.48 | 0.39 | - | ||
| 2020/10 | 2.99 | 7.1 | -2.69 | 21.89 | -26.01 | 8.43 | 0.39 | - | ||
| 2020/9 | 2.79 | 5.91 | -9.7 | 18.91 | -28.67 | 7.7 | 0.27 | - | ||
| 2020/8 | 2.64 | 16.47 | -18.88 | 16.12 | -31.14 | 7.27 | 0.28 | - | ||
| 2020/7 | 2.27 | -4.4 | -28.1 | 13.48 | -33.12 | 7.06 | 0.29 | - | ||
| 2020/6 | 2.37 | -2.46 | -26.53 | 11.21 | -34.1 | 7.06 | 0.31 | - | ||
| 2020/5 | 2.43 | 7.6 | -36.54 | 8.84 | -35.82 | 6.67 | 0.33 | - | ||
| 2020/4 | 2.26 | 14.03 | -35.53 | 6.41 | -35.54 | 5.03 | 0.44 | - | ||
| 2020/3 | 1.98 | 151.28 | -22.88 | 4.15 | -35.54 | 4.15 | 0.46 | - | ||
| 2020/2 | 0.79 | -42.95 | -55.92 | 2.17 | -43.9 | 4.41 | 0.43 | 新冠肺炎疫情影響復工 | ||
| 2020/1 | 1.38 | -38.32 | -33.56 | 1.38 | -33.56 | 0.0 | N/A | - | ||
| 2019/12 | 2.24 | -22.34 | 66.98 | 34.71 | 110.54 | 0.0 | N/A | 因新產品出貨數量增加所致。 |
| 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 |
|---|---|---|---|---|---|---|---|---|---|
| 2024/1 | 1.83 | 2023/1 | 0.89 | 2022/1 | 2.0 | 2021/1 | 2.72 | 2020/1 | 1.38 |
| 2024/2 | 1.38 | 2023/2 | 1.09 | 2022/2 | 1.34 | 2021/2 | 2.22 | 2020/2 | 0.79 |
| 2024/3 | 1.42 | 2023/3 | 1.19 | 2022/3 | 2.21 | 2021/3 | 2.72 | 2020/3 | 1.98 |
| 2024/4 | 1.54 | 2023/4 | 1.13 | 2022/4 | 1.97 | 2021/4 | 2.57 | 2020/4 | 2.26 |
| 2024/5 | 1.62 | 2023/5 | 1.32 | 2022/5 | 1.39 | 2021/5 | 2.07 | 2020/5 | 2.43 |
| 2024/6 | 1.57 | 2023/6 | 1.1 | 2022/6 | 0.83 | 2021/6 | 1.61 | 2020/6 | 2.37 |
| 2024/7 | 1.72 | 2023/7 | 1.26 | 2022/7 | 0.85 | 2021/7 | 1.46 | 2020/7 | 2.27 |
| 2024/8 | 1.7 | 2023/8 | 1.51 | 2022/8 | 0.92 | 2021/8 | 1.56 | 2020/8 | 2.64 |
| 2024/9 | 1.64 | 2023/9 | 1.53 | 2022/9 | 1.15 | 2021/9 | 1.88 | 2020/9 | 2.79 |
| 2024/10 | 1.54 | 2023/10 | 1.58 | 2022/10 | 0.93 | 2021/10 | 1.72 | 2020/10 | 2.99 |
| 2024/11 | 1.52 | 2023/11 | 1.5 | 2022/11 | 1.2 | 2021/11 | 1.81 | 2020/11 | 2.69 |
| N/A | N/A | 2023/12 | 1.37 | 2022/12 | 1.06 | 2021/12 | 1.86 | 2020/12 | 2.35 |
- 每季的合約負債通常會反應在未來半年到一年後的營收
| 合約負債 QoQ YoY | |||
|---|---|---|---|
| 24Q3 (20) | 0.8 | -18.37 | -9.09 |
| 24Q2 (19) | 0.98 | -4.85 | 6.52 |
| 24Q1 (18) | 1.03 | 14.44 | 27.16 |
| 23Q4 (17) | 0.9 | 2.27 | 9.76 |
| 23Q3 (16) | 0.88 | -4.35 | -6.38 |
| 23Q2 (15) | 0.92 | 13.58 | -1.08 |
| 23Q1 (14) | 0.81 | -1.22 | -16.49 |
| 22Q4 (13) | 0.82 | -12.77 | 1.23 |
| 22Q3 (12) | 0.94 | 1.08 | 5.62 |
| 22Q2 (11) | 0.93 | -4.12 | -2.11 |
| 22Q1 (10) | 0.97 | 19.75 | -3.96 |
| 21Q4 (9) | 0.81 | -8.99 | -28.32 |
| 21Q3 (8) | 0.89 | -6.32 | -21.93 |
| 21Q2 (7) | 0.95 | -5.94 | -29.1 |
| 21Q1 (6) | 1.01 | -10.62 | -29.86 |
| 20Q4 (5) | 1.13 | -0.88 | -27.1 |
| 20Q3 (4) | 1.14 | -14.93 | 0.0 |
| 20Q2 (3) | 1.34 | -6.94 | 0.0 |
| 20Q1 (2) | 1.44 | -7.1 | 0.0 |
| 19Q4 (1) | 1.55 | 0.0 | 0.0 |
